Seeing Is Believing
Currently out of the existing stock ratings of Douglas Miehm, 16 are a HOLD (36.36%), 28 are a BUY (63.64%).
Analyst Douglas Miehm, currently employed at RBC, carries an average stock price target met ratio of 60.39% that have a potential upside of 37.86% achieved within 146 days.
Douglas Miehm’s has documented 88 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BHC, Bausch Health Companies at 01-Nov-2024.
Analyst best performing recommendations are on AUPH (AURINIA PHARMACEUTICALS).
The best stock recommendation documented was for BHC (BAUSCH HEALTH COMPANIES) at 5/5/2023. The price target of $8 was fulfilled within 13 days with a profit of $2.17 (37.22%) receiving and performance score of 28.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$13
$3.97 (43.96%)
$13
3 months 15 days ago
(06-Sep-2024)
10/22 (45.45%)
$5.74 (79.06%)
579
Buy
$8
$-1.03 (-11.41%)
$11
10 months 5 days ago
(16-Feb-2024)
8/12 (66.67%)
$2.15 (36.75%)
152
Buy
$13
2 years 1 months 17 days ago
(04-Nov-2022)
5/9 (55.56%)
$4.73 (57.19%)
203
Buy
$12
$2.97 (32.89%)
$22
2 years 1 months 17 days ago
(04-Nov-2022)
1/4 (25%)
$6.85 (133.01%)
266
Buy
$35
$27.23 (350.45%)
$30
3 years 4 months 15 days ago
(06-Aug-2021)
1/2 (50%)
$17.83 (121.90%)
326
Which stock is Douglas Miehm is most bullish on?
Which stock is Douglas Miehm is most reserved on?
What Year was the first public recommendation made by Douglas Miehm?